Aarey Drugs Standalone March 2024 Net Sales at Rs 210.35 crore, up 32.98 percent Y-o-Y - Moneycontrol
| AAREYDRUGS | 58.17 0.21 0.36% |
Slightly above 56% of Aarey Drugs' investor base is looking to short. The analysis of overall sentiment of trading Aarey Drugs Pharmaceuticals stock suggests that many investors are alarmed at this time. Aarey Drugs' investing sentiment overview a quick insight into current market opportunities from investing in Aarey Drugs Pharmaceuticals. Many technical investors use Aarey Drugs Pharmace stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Aarey Drugs stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Aarey daily returns and investor perception about the current price of Aarey Drugs Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Aarey |
Aarey Drugs Standalone March 2024 Net Sales at Rs 210.35 crore, up 32.98 percent Y-o-Y Moneycontrol
Read at news.google.com
 |
Aarey Drugs Fundamental Analysis
We analyze Aarey Drugs' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aarey Drugs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aarey Drugs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Aarey Drugs is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Aarey Drugs Pharmace Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aarey Drugs stock to make a market-neutral strategy. Peer analysis of Aarey Drugs could also be used in its relative valuation, which is a method of valuing Aarey Drugs by comparing valuation metrics with similar companies.
Peers
Aarey Drugs Related Equities
| 3MINDIA | 3M India | 0.94 | ||||
| PAGEIND | Page Industries | 0.35 | ||||
| MRF | MRF | 0.70 | ||||
| HONAUT | Honeywell Automation | 1.12 |
Additional Tools for Aarey Stock Analysis
When running Aarey Drugs' price analysis, check to measure Aarey Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarey Drugs is operating at the current time. Most of Aarey Drugs' value examination focuses on studying past and present price action to predict the probability of Aarey Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarey Drugs' price. Additionally, you may evaluate how the addition of Aarey Drugs to your portfolios can decrease your overall portfolio volatility.